- Managing Director, Synergy Life Science Partners, LP
- Chair, CRV Advisory Board
William N. Starling is Managing Director of Synergy Life Science Partners, LP, a $143 million Venture Capital Partnership and Chief Executive Officer of Synecor, LLC, (Synecor) a business generator of new Life Science companies based in Research Triangle Park (RTP), North Carolina. Synecor has significant academic, scientific, physician, venture capital, corporate, and investment banking partnerships and is focusing its efforts on the identification and development of proprietary, disruptive technologies with extraordinary market potential in the life sciences field.
As CEO of Synecor, Mr. Starling is a cofounder of BaroSense, Inc., Bioerodible Vascular Solutions, Inc., (BVS, acquired by Guidant/Abbott in March 2003), InnerPulse, Inc., TransEnterix, Inc. (NYSE:TRXC), Interventional Autonomics Corporation, NeuroTronik Limited, and Conveyor Cardiovascular Limited, the initial seven companies founded and incubated by Synecor. Mr. Starling currently serves as CEO of Conveyor Cardiovascular Limited, an Irish-based company in the structural heart field; and as a board member of TransEnterix, Inc. (NYSE: TRXC), a RTP, NC – based robotic surgery company pioneering digital laparoscopic robotic surgery worldwide. Mr. Starling was on the Board of iRhythm Technologies, Inc. (NASDAQ: IRTC) in San Francisco, a Stanford BioDesign spinout, from its inception in January 2007 until its initial public offering October 20, 2016. Mr. Starling is Chairman of the Board of RTP, NC – based InnAVasc, Inc., an early-stage startup company spun out of the Duke University Medical Center engaged in the development of improved renal dialysis technology. Recent Board memberships/personal investments include YORLABS, Inc. in the Handheld Ultrasound field, Senaptec, Inc. in the Sensory Performance field (represents investor Carolina Angel Network), and EnCompass Technologies, Inc. in the Embolic Protection field.
Mr. Starling serves on the Stanford Stroke Center’s Board of Advisors at the Stanford University Medical Center. He also serves on the Kenan-Flagler Business School Board of Advisors (Chairman 2009-2014), is Chairman of the UNC/NCSU Department of Biomedical Engineering Industrial Advisory Board and the Chancellor’s Innovation Circle at the University of North Carolina at Chapel Hill where he frequently guest-lectures to undergraduate and graduate students on entrepreneurism.